194 related articles for article (PubMed ID: 22463740)
1. The role of stem cells in muscular dystrophies.
Meregalli M; Farini A; Colleoni F; Cassinelli L; Torrente Y
Curr Gene Ther; 2012 Jun; 12(3):192-205. PubMed ID: 22463740
[TBL] [Abstract][Full Text] [Related]
2. Stem cell therapies to treat muscular dystrophy: progress to date.
Meregalli M; Farini A; Parolini D; Maciotta S; Torrente Y
BioDrugs; 2010 Aug; 24(4):237-47. PubMed ID: 20623990
[TBL] [Abstract][Full Text] [Related]
3. Stem Cell Differentiation Toward the Myogenic Lineage for Muscle Tissue Regeneration: A Focus on Muscular Dystrophy.
Ostrovidov S; Shi X; Sadeghian RB; Salehi S; Fujie T; Bae H; Ramalingam M; Khademhosseini A
Stem Cell Rev Rep; 2015 Dec; 11(6):866-84. PubMed ID: 26323256
[TBL] [Abstract][Full Text] [Related]
4. Stem cell-based therapies for Duchenne muscular dystrophy.
Sun C; Serra C; Lee G; Wagner KR
Exp Neurol; 2020 Jan; 323():113086. PubMed ID: 31639376
[TBL] [Abstract][Full Text] [Related]
5. Perspectives of stem cell therapy in Duchenne muscular dystrophy.
Meregalli M; Farini A; Belicchi M; Parolini D; Cassinelli L; Razini P; Sitzia C; Torrente Y
FEBS J; 2013 Sep; 280(17):4251-62. PubMed ID: 23206279
[TBL] [Abstract][Full Text] [Related]
6. Cell based therapy for Duchenne muscular dystrophy.
Farini A; Razini P; Erratico S; Torrente Y; Meregalli M
J Cell Physiol; 2009 Dec; 221(3):526-34. PubMed ID: 19688776
[TBL] [Abstract][Full Text] [Related]
7. Repair or replace? Exploiting novel gene and cell therapy strategies for muscular dystrophies.
Benedetti S; Hoshiya H; Tedesco FS
FEBS J; 2013 Sep; 280(17):4263-80. PubMed ID: 23387802
[TBL] [Abstract][Full Text] [Related]
8. Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy.
Siemionow M; Cwykiel J; Heydemann A; Garcia-Martinez J; Siemionow K; Szilagyi E
Stem Cell Rev Rep; 2018 Apr; 14(2):189-199. PubMed ID: 29305755
[TBL] [Abstract][Full Text] [Related]
9. Cell therapy in Duchenne muscular dystrophy treatment: clinical trials overview.
Bajek A; Porowinska D; Kloskowski T; Brzoska E; Ciemerych MA; Drewa T
Crit Rev Eukaryot Gene Expr; 2015; 25(1):1-11. PubMed ID: 25955813
[TBL] [Abstract][Full Text] [Related]
10. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update.
Sun C; Shen L; Zhang Z; Xie X
Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32717791
[TBL] [Abstract][Full Text] [Related]
12. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
Lala-Tabbert N; Fu D; Wiper-Bergeron N
Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
[TBL] [Abstract][Full Text] [Related]
13. Restoration of Functional Full-Length Dystrophin After Intramuscular Transplantation of Foamy Virus-Transduced Myoblasts.
Meng J; Sweeney NP; Doreste B; Muntoni F; McClure M; Morgan J
Hum Gene Ther; 2020 Feb; 31(3-4):241-252. PubMed ID: 31801386
[TBL] [Abstract][Full Text] [Related]
14. Myoblast transfer therapy: is there any light at the end of the tunnel?
Mouly V; Aamiri A; Périé S; Mamchaoui K; Barani A; Bigot A; Bouazza B; François V; Furling D; Jacquemin V; Negroni E; Riederer I; Vignaud A; St Guily JL; Butler-Browne GS
Acta Myol; 2005 Oct; 24(2):128-33. PubMed ID: 16550930
[TBL] [Abstract][Full Text] [Related]
15. Biomedical applications of muscle-derived stem cells: from bench to bedside.
Tamaki T
Expert Opin Biol Ther; 2020 Nov; 20(11):1361-1371. PubMed ID: 32643444
[TBL] [Abstract][Full Text] [Related]
16. Muscle-derived stem cells: potential for muscle regeneration.
Huard J; Cao B; Qu-Petersen Z
Birth Defects Res C Embryo Today; 2003 Aug; 69(3):230-7. PubMed ID: 14671776
[TBL] [Abstract][Full Text] [Related]
17. Mural cells paint a new picture of muscle stem cells.
Morgan J; Muntoni F
Nat Cell Biol; 2007 Mar; 9(3):249-51. PubMed ID: 17330116
[No Abstract] [Full Text] [Related]
18. Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion.
Gonçalves MA; de Vries AA; Holkers M; van de Watering MJ; van der Velde I; van Nierop GP; Valerio D; Knaän-Shanzer S
Hum Mol Genet; 2006 Jan; 15(2):213-21. PubMed ID: 16321987
[TBL] [Abstract][Full Text] [Related]
19. Human Skeletal Muscle Cells Derived from the Orbicularis Oculi Have Regenerative Capacity for Duchenne Muscular Dystrophy.
Yamanaka Y; Takenaka N; Sakurai H; Ueno M; Kinoshita S; Sotozono C; Sato T
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31337111
[TBL] [Abstract][Full Text] [Related]
20. Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro.
Vieira NM; Brandalise V; Zucconi E; Jazedje T; Secco M; Nunes VA; Strauss BE; Vainzof M; Zatz M
Biol Cell; 2008 Apr; 100(4):231-41. PubMed ID: 17997718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
